Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 175 Records) |
Query Trace: Recurrence and PIK3CA[original query] |
---|
Unraveling molecular mechanisms of head and neck cancer. Critical reviews in oncology/hematology 2022 8 178 103778. Antra , Parashar Palak, Hungyo Hungharla, Jain Anuja, Ahmad Shandar, Tandon Vib |
Molecular characterization-based multi-omics analyses in primary liver cancer using the Japanese version of the genome atlas. Journal of hepato-biliary-pancreatic sciences 2022 8 . Imamura Taisuke, Okamura Yukiyasu, Ohshima Keiichi, Uesaka Katsuhiko, Sugiura Teiichi, Yamamoto Yusuke, Ashida Ryo, Ohgi Katsuhisa, Nagashima Takeshi, Yamaguchi K |
NF2 Alteration/22q Loss Is Associated with Recurrence in WHO Grade 1 Sphenoid Wing Meningiomas. Cancers 2022 Jun 14 (13): . Sakai Yu, Miyawaki Satoru, Teranishi Yu, Okano Atsushi, Ohara Kenta, Hongo Hiroki, Ishigami Daiichiro, Shimada Daisuke, Mitsui Jun, Nakatomi Hirofumi, Saito Nobuhi |
Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis. Pathology 2022 Jun . Tsang Julia Y, Shao Yan, Poon Ivan K, Ni Yun-Bi, Kwan Johnny S, Chow Chit, Shea Ka-Ho, Tse Gary |
PIK3CA Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy. Current oncology (Toronto, Ont.) 2022 5 29 (5): 2895-2908. Cho Yoon Ah, Ko Seung Yeon, Suh Yong Joon, Kim Sanghwa, Park Jung Ho, Park Hye-Rim, Seo Jinwon, Choi Hyo Geun, Kang Ho Suk, Lim Hyun, Park Ha Young, Kwon Mi Ju |
Genetic variations in triple-negative breast cancers undergoing neo-adjuvant chemotherapy. Cancer drug resistance (Alhambra, Calif.) 2022 5 2 (3): 877-884. Mori Miki, Watanabe Tomoko, Akashi-Tanaka Sadako, Ueda Kumiko, Makino Reiko, Hirota Yuko, Nakamura Sei |
PIK3CA-AKT pathway predominantly acts in developing ipsilateral breast tumor recurrence long after breast-conserving surgery. Breast cancer research and treatment 2022 3 193 (2): 349-359. Nakagomi Hiroshi, Inoue Masayuki, Hirotsu Yosuke, Amemiya Kenji, Mochiduki Hitoshi, Omata Mas |
Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma. Cancer science 2022 3 113 (5): 1712-1721. Kobayashi Kato Mayumi, Asami Yuka, Takayanagi Daisuke, Matsuda Maiko, Shimada Yoko, Hiranuma Kengo, Kuno Ikumi, Komatsu Masaaki, Hamamoto Ryuji, Matsumoto Koji, Ishikawa Mitsuya, Kohno Takashi, Kato Tomoyasu, Shiraishi Kouya, Yoshida Hiros |
Genetic landscape and personalized tracking of tumor mutations in Vietnamese women with breast cancer. Molecular oncology 2022 12 . Nguyen Hoang Van-Anh, Nguyen Sao Trung, Nguyen Trieu Vu, Pham Thanh Huyen, Doan Phuoc Loc, Nguyen Thi Ngoc Thanh, Nguyen Minh Long, Dinh Thi Cuc, Pham Dinh Hoang, Nguyen Ngoc Mai, Nguyen Duy Sinh, Nguyen Du Quyen, Lu Y-Thanh, Do Thanh Thuy Thi, Truong Dinh Kiet, Phan Minh-Duy, Nguyen Hoai-Nghia, Giang Hoa, Tu Lan |
Association between PIK3CA Mutations in Blood and Tumor-Infiltrating Lymphocytes in Peruvian Breast Cancer Patients. Asian Pacific journal of cancer prevention : APJCP 2022 10 23 (10): 3331-3337. Castaneda Carlos A, Castillo Miluska, Bernabe Luis A, Suarez Nancy, Romero Atocha, Sanchez Joselyn, Torres Ebert, Enciso Javier, Tello Katherine, Enciso Nataly, Velarde Marco, De La Cruz Miguel, Dunstan Jorge, Cotrina Jose M, Abugattas Julio, Pinillos Miguel, Roque Katia, Fuentes Hugo, Poquioma Ebert, Guerra Henry, Gomez Henry |
PIK3CA-mutations in breast cancer. Breast cancer research and treatment 2022 Oct . Reinhardt Kristin, Stückrath Kathrin, Hartung Carolin, Kaufhold Sandy, Uleer Christoph, Hanf Volker, Lantzsch Tillmann, Peschel Susanne, John Jutta, Pöhler Marleen, Bauer Marcus, Bürrig Friedrich Karl, Weigert Edith, Buchmann Jörg, Kantelhardt Eva Johanna, Thomssen Christoph, Vetter Marti |
Association of Pathway Mutations With Survival in Taiwanese Breast Cancers. Frontiers in oncology 2022 12 819555. Yang Po-Sheng, Chao Ying-Ting, Lung Chun-Fan, Liu Chien-Liang, Chang Yuan-Ching, Li Ker-Chau, Hsu Yi-Chiu |
Glioma genetic profiles associated with electrophysiologic hyperexcitability. Neuro-oncology 2023 9 . Steven Tobochnik, Maria Kristina C Dorotan, Hia S Ghosh, Emily Lapinskas, Jayne Vogelzang, David A Reardon, Keith L Ligon, Wenya Linda Bi, Stelios M Smirnakis, Jong Woo L |
EGFR co-mutation is associated with the risk of recurrence in invasive lung adenocarcinoma with the micropapillary component. Asian journal of surgery 2023 8 . Haixin Kang, Haiyan Lv, Tao-Hsin Tung, Dehua Ma, Zheng Wang, Juping Du, Kai Zhou, Juan Pan, Yanjie Zhang, Shuotao Peng, Zhaonan Yu, Bo Shen, Minhua |
Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients. Frontiers in immunology 2023 6 14 1188030. Oliver Hoffmann, Sebastian Wormland, Ann-Kathrin Bittner, Julian Hölzenbein, Esther Schwich, Sabine Schramm, Hana Rohn, Peter A Horn, Rainer Kimmig, Sabine Kasimir-Bauer, Vera Rebma |
Evaluation of the Analytical Performance of Oncomine Lung cfDNA Assay for Detection of Plasma EGFR Mutations. Genes 2023 6 14 (6): . Yong Gon Cho, Joonhong Park, Ji Yoon Han, Tae Yun K |
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study. Journal of clinical pathology 2023 6 . Federica Miglietta, Valentina Carraro, Ottavia Amato, Gaia Griguolo, Michele Bottosso, Giada Munari, Giovanni Zarrilli, Marcello Lo Mele, Caterina Barbieri, Angelo Paolo Dei Tos, Valentina Guarneri, Maria Vittoria Dieci, Matteo Fass |
Significance of the FGFR3 mutation in Chinese patients with bladder cancer. Translational andrology and urology 2023 6 12 (5): 761-769. Lanxiang Hao, Jiang Fang, Ran Xu, Shuo Liu, Guangcheng Luo, Xinjun Wa |
The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers. Journal of neurosurgery 2023 4 1-11. Passeri Thibault, Gutman Tom, Hamza Abderaouf, Adle-Biassette Homa, Girard Elodie, Beaurepere Romane, Tariq Zakia, Mariani Odette, Dahmani Ahmed, Bourneix Christine, Abbritti Rosaria, Driouch Keltouma, Bohec Mylène, Servant Nicolas, Baulande Sylvain, Decaudin Didier, Guichard Jean-Pierre, Calugaru Valentin, Feuvret Loïc, Guinebretière Jean-Marc, Champion Laurence, Bièche Ivan, Froelich Sébastien, Mammar Hamid, Masliah-Planchon Juli |
The impact of PIK3CA mutations and PTEN expression on the effect of neoadjuvant therapy for postmenopausal luminal breast cancer patients. BMC cancer 2023 4 23 (1): 384. Shouko Hayama, Rikiya Nakamura, Takayuki Ishige, Takafumi Sangai, Masahiro Sakakibara, Hiroshi Fujimoto, Emi Ishigami, Takahito Masuda, Ayako Nakagawa, Ryotaro Teranaka, Satoshi Ota, Sakae Itoga, Naohito Yamamoto, Takeshi Nagashima, Masayuki Otsu |
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence. Brain tumor pathology 2023 3 . Tamura Ryota, Iwanami Akio, Ohara Kentaro, Nishimoto Masaaki, Pareira Eriel Sandika, Miwa Tomoru, Tsuzaki Naoko, Kuranari Yuki, Morimoto Yukina, Toda Masahiro, Okano Hideyuki, Nakamura Masaya, Yoshida Kazunari, Sasaki Hika |
ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing. Gynecologic oncology 2023 2 171 59-66. Machida Hiroko, Matsuo Koji, Tanaka Masayuki, Kitatani Kanae, Takase Akinori, Yokoyama Keiko, Kajiwara Hiroshi, Yasaka Miwa, Ikeda Masae, Yoshida Hiroshi, Hirasawa Takeshi, Mikami Mik |
Biomarker Data From the Phase III KATHERINE Study of Adjuvant T-DM1 Versus Trastuzumab for Residual Invasive Disease After Neoadjuvant Therapy for HER2-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 2 . Denkert Carsten, Lambertini Chiara, Fasching Peter A, Pogue-Geile Katherine L, Mano Max S, Untch Michael, Wolmark Norman, Huang Chiun-Sheng, Loibl Sibylle, Mamounas Eleftherios P P, Geyer Charles E, Lucas Peter C, Boulet Thomas, Song Chunyan, Lewis Gail D, Nowicka Malgorzata, de Haas Sanne, Basik Ma |
Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer. BMC medicine 2023 12 21 (1): 493. Zhaoyun Liu, Bo Yu, Mu Su, Chenxi Yuan, Cuicui Liu, Xinzhao Wang, Xiang Song, Chao Li, Fukai Wang, Jianli Ma, Meng Wu, Dawei Chen, Jinming Yu, Zhiyong |
Serial circulating-tumor DNA analysis with a tumor naïve next-generation sequencing panel detects minimal residual disease and predicts outcome in ovarian cancer. Cancer research 2023 12 . Jinho Heo, Yoo-Na Kim, Saeam Shin, Kyunglim Lee, Ji-Hyun Lee, Yong Jae Lee, Zisun Choi, Jihyang Park, Seungki Min, Sang Wun Kim, Jong Rak Choi, Sunghoon Kim, Seung-Tae Lee, Jung-Yun L |
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy. British journal of cancer 2023 11 . Luca Licata, Marco Barreca, Barbara Galbardi, Matteo Dugo, Giulia Viale, Balàzs Gy?rffy, Thomas Karn, Lajos Pusztai, Luca Gianni, Maurizio Callari, Giampaolo Bianchi |
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women. Annals of oncology : official journal of the European Society for Medical Oncology 2023 1 . Luen S J, Viale G, Nik-Zainal S, Savas P, Kammler R, Dell'Orto P, Biasi O, Degasperi A, Brown L C, Láng I, MacGrogan G, Tondini C, Bellet M, Villa F, Bernardo A, Ciruelos E, Karlsson P, Neven P, Climent M, Müller B, Joshum W, Bonnefoi H, Martino S, Davidson N E, Geyer C, Chia S K, Ingle J N, Coleman R, Solbach C, Thürlimann B, Colleoni M, Coates A S, Goldhirsch A, Fleming G F, Francis P A, Speed T P, Regan M M, Loi |
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example. Molecular biomedicine 2024 4 5 (1): 13. Shutao Zheng, Shuo He, Yan Liang, Yiyi Tan, Qing Liu, Tao Liu, Xiaomei |
Association of preoperative and postoperative circulating tumour DNA (ctDNA) with PIK3CA gene mutation with risk of recurrence in patients with non-metastatic breast cancer. Surgical oncology 2024 4 54 102060. Fara Hassan, Jiang Huai Wang, Donal Peter O'Leary, Mark Corrigan, Henry Paul Redmo |
TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort. Advances in therapy 2024 1 . Sergio D Cruz-Romero, Sebastián González, José Y Juez, David S Becerra, Ana M Baldión, José A Hakim, Deyanira González-Devia, Sandra Perdomo, Paula A Rodríguez-Urre |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: